Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients

NCT05176470 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Melanoma
Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
Pathologic Stage IIIC Cutaneous Melanoma AJCC v8
Pathologic Stage IIID Cutaneous Melanoma AJCC v8
Stage IV Melanoma

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: Lifileucel
BIOLOGICAL: Pembrolizumab
PROCEDURE: Therapeutic Conventional Surgery

Sponsor

Richard Wu

Collaborators

[object Object]